Pfizer Deal Signals a Move Into Treating Rare Diseases
Wednesday, December 2, 2009 - 01:35
in Health & Medicine
Pfizer said that it had licensed the worldwide rights to a treatment for Gaucher disease, a genetic disorder, putting Pfizer into competition with Genzyme.